Fluid overload is associated with use of a higher number of antihypertensive drugs in hemodialysis patients

Abstract

Introduction Hypertension is multifactorial, highly prevalent in the hemodialysis (HD) population and its adequate control requires, in addition to adequate volume management, often the use of multiple antihypertensive drugs. We aimed to describe the use of antihypertensive agents in a group of HD patients and to evaluate the factors associated with the use of multiple classes (≥3) of antihypertensives. Methods We analyzed the baseline data from the HDFit study. Clinically stable patients with HD vintage between 3 and 24 months without any severe mobility limitation were recruited from sites throughout southern Brazil. Fluid status was measured pre‐dialysis with the Body Composition Monitor (BCM; Fresenius, Germany). Fluid overload (FO) was considered when the overhydration index (OH) was greater than 7% of extracellular water (OH/ECW > 7%) and overweight was defined as a body mass index (BMI) greater than 25 kg/m2. Prescriptions of antihypertensive drugs were obtained from participants' reports and medical records. Logistic regression was employed to determine factors associated with excessive use of antihypertensive medication (≥3 classes). Findings Of 195 studied patients, 171 with complete data were included (70% male, 53 ± 15 years old, 57% of them with FO). Pre‐dialysis systolic blood pressure (SBP) was 150 ± 24 mmHg and patients used a median of 2 (1–3) antihypertensive drugs. Vasodilators (20%) were of lowest prevalence, use of other classes varied from 40% to 53%. Sixty‐two (36%) subjects used ≥3 classes and presented a higher prevalence of diabetes and FO, lower prevalence of overweight, and higher SBP. In a logistic regression model age, BMI <25 kg/m2, and OH/ECW > 7% were associated with excessive drug use. Discussion More than one‐third of participants used ≥3 classes of antihypertensive drugs, and it was associated with older age, BMI <25 kg/m2 and FO. Strategies that better manage FO may aid better blood pressure control and avoid the use of multiple antihypertensive medications.

High prevalence of hyperkalemia in Brazilian chronic dialysis patients and differences across geographic regions

“…In a Brazilian multicenter study with 195 hemodialysis participants, 53% used beta-blockers and 45% RAAS. 12 Changes in dialysis prescriptions by extending dialysis sessions or increasing their frequency, may be difficult to implement due to logistics and public healthcare reimbursement restrictions. It can also affect adequate control of potassium levels.…”

“…In a Brazilian multicenter study with 195 hemodialysis participants, 53% used beta-blockers and 45% RAAS. 12 …”

Prevalência elevada de hipercalemia em pacientes brasileiros em diálise crônica e diferenças entre as regiões geográficas

“…Outra causa possível é o amplo uso de medicamentos hipercalêmicos. Em um estudo multicêntrico brasileiro com 195 participantes em hemodiálise, 53% utilizavam betabloqueadores e 45% inibidores do SRAA 12 .…”

Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy

“…While these tools play an important role in nutritional assessment, the fact that they rely on subjective assessments that could be easily varied and swayed by individual examiners makes these screening mechanisms incomparable and unsatisfactory. Additionally, some non-nutritional factors such as inflammation, fluid status, renal dysfunction, and hepatic congestion also exert diverse effects on indicators like serum albumin and BMI ( 43 , 44 ), effectively exposing these tools to additional noises. Thus, it is neither sufficient nor precise to evaluate patients' nutritional risk with regard to their cancer prognosis and treatment efficacy only by their BMI or albumin status.…”